Combination of Diane-35 and Cangfu Daotan Wan Effectively Ameliorates Inflammatory Response, Stress State, and Hormone Levels in Patients with Polycystic Ovary Syndrome (PCOS), Leading to Significant Improvement in Clinical Treatment Outcomes.

IF 2.6 4区 医学 Q2 OBSTETRICS & GYNECOLOGY
International Journal of Women's Health Pub Date : 2025-07-29 eCollection Date: 2025-01-01 DOI:10.2147/IJWH.S526092
Li Chen, Cai-Ping Fang, Yan Chen, Wei-Hua Gu, Sai-Li Wang, Ning Niu, Qin-Hua Zhang
{"title":"Combination of Diane-35 and Cangfu Daotan Wan Effectively Ameliorates Inflammatory Response, Stress State, and Hormone Levels in Patients with Polycystic Ovary Syndrome (PCOS), Leading to Significant Improvement in Clinical Treatment Outcomes.","authors":"Li Chen, Cai-Ping Fang, Yan Chen, Wei-Hua Gu, Sai-Li Wang, Ning Niu, Qin-Hua Zhang","doi":"10.2147/IJWH.S526092","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess the impact of combining Diane-35 with Cangfu Daotan Wan on inflammatory response, stress response, and hormone levels in patients with polycystic ovary syndrome (PCOS), and to offer insights for clinical management.</p><p><strong>Methods: </strong>A retrospective analysis was conducted from January 2022 to March 2024, encompassing PCOS patients treated at our hospital who fulfilled the inclusion criteria. Patients were categorized into two groups: the study group receiving Diane-35 plus Cangfu Daotan Wan, and the control group receiving Diane-35 alone. Comparisons were made between the two groups regarding inflammatory markers, stress response indicators, hormone levels, and overall treatment efficacy.</p><p><strong>Results: </strong>Post-treatment, the study group exhibited a lower incidence of polycystic ovarian changes and a higher overall efficacy rate compared to the control group (P<0.05). Inflammatory factors IL-6, TNF-α, and MCP-1 were significantly reduced in the study group versus the control group (P<0.05). Oxidative stress markers SOD and GSH were significantly elevated, while GSS was significantly decreased in the study group compared to the control group (P<0.05). No significant differences were observed in FSH, LH, LH/FSH ratio, or testosterone levels between the two groups (P>0.05). The BMI index was significantly lower in the study group than in the control group (P<0.05). Additionally, traditional Chinese medicine symptom scores were significantly reduced in the study group compared to the control group (P<0.05).</p><p><strong>Conclusion: </strong>The combination of Diane-35 and Cangfu Daotan Wan effectively ameliorates inflammatory response and stress state, modulates hormone levels, and enhances clinical treatment outcomes in PCOS patients. This combined therapy is both safe and efficacious, warranting further application in clinical practice.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"2353-2364"},"PeriodicalIF":2.6000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12317708/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Women's Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJWH.S526092","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To assess the impact of combining Diane-35 with Cangfu Daotan Wan on inflammatory response, stress response, and hormone levels in patients with polycystic ovary syndrome (PCOS), and to offer insights for clinical management.

Methods: A retrospective analysis was conducted from January 2022 to March 2024, encompassing PCOS patients treated at our hospital who fulfilled the inclusion criteria. Patients were categorized into two groups: the study group receiving Diane-35 plus Cangfu Daotan Wan, and the control group receiving Diane-35 alone. Comparisons were made between the two groups regarding inflammatory markers, stress response indicators, hormone levels, and overall treatment efficacy.

Results: Post-treatment, the study group exhibited a lower incidence of polycystic ovarian changes and a higher overall efficacy rate compared to the control group (P<0.05). Inflammatory factors IL-6, TNF-α, and MCP-1 were significantly reduced in the study group versus the control group (P<0.05). Oxidative stress markers SOD and GSH were significantly elevated, while GSS was significantly decreased in the study group compared to the control group (P<0.05). No significant differences were observed in FSH, LH, LH/FSH ratio, or testosterone levels between the two groups (P>0.05). The BMI index was significantly lower in the study group than in the control group (P<0.05). Additionally, traditional Chinese medicine symptom scores were significantly reduced in the study group compared to the control group (P<0.05).

Conclusion: The combination of Diane-35 and Cangfu Daotan Wan effectively ameliorates inflammatory response and stress state, modulates hormone levels, and enhances clinical treatment outcomes in PCOS patients. This combined therapy is both safe and efficacious, warranting further application in clinical practice.

Abstract Image

Abstract Image

Abstract Image

戴安-35联合苍腑导痰丸有效改善多囊卵巢综合征(PCOS)患者的炎症反应、应激状态及激素水平,显著改善临床治疗效果。
目的:评价黛安-35联合苍腑导痰丸对多囊卵巢综合征(PCOS)患者炎症反应、应激反应及激素水平的影响,为临床治疗提供参考。方法:回顾性分析2022年1月至2024年3月在我院治疗的符合纳入标准的PCOS患者。将患者分为两组:研究组联合苍腑导痰丸治疗,对照组单独治疗。比较两组患者炎症指标、应激反应指标、激素水平及整体治疗效果。结果:治疗后,研究组多囊卵巢病变发生率低于对照组,总有效率高于对照组(P0.05)。研究组患者的BMI指数明显低于对照组(p)结论:复方丹宁-35联合苍腑导痰丸可有效改善PCOS患者的炎症反应和应激状态,调节激素水平,提高临床治疗效果。该联合疗法安全有效,值得进一步在临床实践中应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Women's Health
International Journal of Women's Health OBSTETRICS & GYNECOLOGY-
CiteScore
3.70
自引率
0.00%
发文量
194
审稿时长
16 weeks
期刊介绍: International Journal of Women''s Health is an international, peer-reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of women''s healthcare including gynecology, obstetrics, and breast cancer. Subject areas include: Chronic conditions including cancers of various organs specific and not specific to women Migraine, headaches, arthritis, osteoporosis Endocrine and autoimmune syndromes - asthma, multiple sclerosis, lupus, diabetes Sexual and reproductive health including fertility patterns and emerging technologies to address infertility Infectious disease with chronic sequelae including HIV/AIDS, HPV, PID, and other STDs Psychological and psychosocial conditions - depression across the life span, substance abuse, domestic violence Health maintenance among aging females - factors affecting the quality of life including physical, social and mental issues Avenues for health promotion and disease prevention across the life span Male vs female incidence comparisons for conditions that affect both genders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信